Both in Biotechnology
Pluri vs aTyr Pharma
Over the past year PLUR returned −65.3% and ATYR returned −81.3%; their daily moves had a correlation of 0.06.
PLUR −65.3% ATYR −81.3%Growth of $1, one year, split-adjusted
| Metric | PLUR | ATYR |
|---|---|---|
| Price | $1.23 | $6.18 |
| Market cap | $16.6M | $15.4M |
| Today | −3.15% | −6.79% |
| 1 month | +24.2% | −45.5% |
| 6 months | −62.7% | −85.1% |
| Year to date | −58.9% | −80.3% |
| 1 year | — | −82.5% |
| Revenue growth (YoY) | −15.8% | — |
| Gross margin | 58.5% | — |
| Net margin | −1755.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 16.4× | 81.3× |
| Net cash | -$23.9M | $56.9M |
| Dividend yield | — | — |
| Volatility (60d) | 81.3% | 1,072.3% |
| Short % of float | 0.3% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).